Association of serum interleukin-17 level with early recurrence and prognosis after radical surgery in hepatocellular carcinoma patients with different levels of alpha-fetoprotein

Deng WeiWei; Zhu WenMing; Yi Chao; Feng YangChun; Huang YanChun

doi:10.3969/j.issn.1001-5256.2018.02.016

Issue 2

Feb. 2018

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2018 > 34(2): 298-302

PDF( 263 KB)

Association of serum interleukin-17 level with early recurrence and prognosis after radical surgery in hepatocellular carcinoma patients with different levels of alpha-fetoprotein

DOI: 10.3969/j.issn.1001-5256.2018.02.016

Department of Clinical Laboratory, The Affiliated Tumor Hospital of Xinjiang Medical University

Research funding:

Published Date: 2018-02-20

Abstract

Abstract

Objective To investigate the expression of interleukin-17 (IL-17) in hepatitis B virus (HBV) -related hepatocellular carcinoma (HCC) with different levels of alpha-fetoprotein (AFP) , as well as its association with recurrence and prognosis after radical treatment for HCC.Methods A total of 167 patients with HBV-related HCC who underwent radical resection in The Affiliated Tumor Hospital of Xinjiang Medical University from January 2013 to December 2014 were enrolled, and 115 patients with hepatic hemangioma (including 83 HBV carriers) were enrolled as control group.ELISA was used to measure the serum level of IL-17 in 167 patients with HBV-related HCC, and electrochemical luminescence was used to measure the serum level of AFP.The correlation between the expression of IL-17 and the serum level of AFP was analyzed, as well as the association of the expression of IL-17 with recurrence and survival after radical resection of HCC.The chi-square test was used for comparison of categorical data between groups, and the Kaplan-Meier method, log-rank test, and Cox proportional hazards model were used for survival analysis.Results The patients with HBV-related HCC were divided into two groups according to the serum level of AFP, and there was a significant difference in the positive expression rate of IL-17 between AFP <400 ng/ml group and AFP≥400 ng/ml group [50.9% (58/114) vs 34.0% (18/53) , χ2= 8.11, P = 0.002]; there were also significant differences between these two groups in disease-free survival (34.1 months vs 13.4 months, χ2= 10.34, P < 0.05) , overall survival (84.2 months vs 57.4 months, χ2= 3.13, P < 0.05) , and tumor recurrence rate within 1 year (28.9% vs 50.9%, χ2= 10.89, P <0.05) .The Kaplan-Meier analysis showed that among the patients with HBV-related HCC and AFP < 400 ng/ml, the patients with positive expression of IL-17 had a significantly higher recurrence rate within 1 year after surgery than those with negative expression of IL-17, as well as significantly shorter disease-free survival and overall survival than those with low expression of IL-17 (χ2= 7.350, 3.814, and9.744, all P < 0.05) .The Cox proportional hazards model showed that positive expression of IL-17, tumor thrombus in vessels, and degree of tumor differentiation were influencing factors for the prognosis of HCC patients (all P < 0.05) .Conclusion For patients with HBV-related HCC and AFP < 400 ng/ml, positive expression of IL-17 indicates early recurrence and poor prognosis.
- cacinoma, hepatocellular,
- alpha-fetoprotein,
- interleukin-17,
- prognosis

FullText(HTML)

References(19)

References

[1]SUKOWATI GH, EL-KHOBA KE, LE SI, et al.Significance of hepatitis virus infection in the oncogenic initiation of hepatocellular carcinoa[J].World J Gastroenterol, 2016, 22 (4) :1497-1512.

[2]LIU XH, ZHAO YM, ZHAO XF, et al.Diagnostic and therapeutic progress on hepatocellular carcinoma[J/CD].Chin J Liver Dis:Electronic Edition, 2017, 9 (2) :20-25. (in Chinese) 刘秀红, 赵一鸣, 赵晓飞, 等.肝细胞癌诊断与治疗研究进展[J/CD].中国肝脏病杂志:电子版, 2017, 9 (2) :20-25.

[3]GEOFFREY J, MARKKOWITZ, GREGORY A, et al.Inflammatory models drastically alter tumor growth and the immune microenvironment in hepatocellular carcinoma[J].Sci Bull (Beijing) , 2015, 60 (8) :762-772.

[4]SOLINI M, KIRILOVSKY A, MLECNIK B, et al.Clinical impact of different glasses of infiltrating T cytotoxic and helper cells (Thl, th2, treg, thl7) in patients with colorectal cancer[J].Cancer Res, 2011, 71 (4) :1263-1271.

[5]STOCKINGER B, VELDHOEN M, MARTIN B, et al.Th17 T cells:linking innate andadaptive irnmunity[J].Semin Immunol, 2007, 19 (6) :353-361.

[6]EDGE SB, BYRD DR, COMPTON CC, et al.AJCC Cancer Staging Manual[M].7th ed.New York:Springer-Verlag, 2010.

[7]LANAYA H, NATARAJAN A, KOMPOSCH K, et al.EGFR has a tumourpromoting role in liver macrohages during hepatocellular carcinoma formation[J].Nat Cell Biol, 2014, 16 (10) :972-977.

[8]BERTINO G, ARDIRI A, MALAGUARNERA M, et al.Hepatocellualar carcinonm serunl markers[J].Semin Oncol, 2012, 39 (4) :410-433.

[9]YAMAMOTO K, IMAMURA H, MATSUYAMA Y, et al.AFP, AFP-L3, DCP, and GP73 as markers for monitoring treatment response and recurrence and as surrogate markers of clinicopathological variables of HCC[J].J Gastroenterol, 2010, 45 (12) :1272-1282.

[10]COLLI A, FRAQUELLI M, CASAZZA G, et al.Accuracy of ultrasonography, spiral CT, mag-netic resonance, and alpha-fetoprotein in diagnosing hepatocellular carcinoma:a systematic review[J].J Gastroenterol, 2006, 101 (3) :513-523.

[11]GAMBARIN-GELWAN M, WOLF DC, SHAPIRO R, et al.Sensitivity of commonly available screening tests in detecting hepatocellular carcinoma in hepatitis C virus cirrhosis[J].Hepatology, 2000, 95 (6) :1535-1538.

[12]LI JY, SONG JY, WANG JF, et al.Value of combined detection of AFP, CA19-9, CEA in early diagnosis of primary liver cancer[J].J Clin Hepatol, 2017, 33 (7) :1291-1295. (in Chinese) 李嘉妍, 宋金云, 王建芳, 等.AFP、CA19-9、CEA联合检测对原发性肝癌的早期诊断价值[J].临床肝胆病杂志, 2017, 33 (7) :1291-1295.

[13]BAE JS, PARK SJ, PARK KB, et al.Acute exacerbation of hepatitis in liver cirrhosis with very high levels of alpha-fetoprotein but no occurrence of hepatocellular carcinoma[J].Korean J Intern Med, 2005, 20 (1) :80-85.

[14]MA WJ, WANG HY, TENG LS, et al.Correlation analysis of preoperative serum alpha-fetoprotein (AFP) level and prognosis of hepatocellular carcinoma (HCC) after hepatectomy[J].World J Surg Oncol, 2013, 11:212.

[15]TU JF, PAN HY, YING XH, et al.Mast cells comprise the major of interleukin 17-producing cells and predict a poor prognosis in hepatocellular carcinoma[J].Medicine (Baltimore) , 2016, 95 (13) :e3220.

[16]AZZAZENE D, AL THAWADI H, AL FARSI H, et al.Plasma endothelial protein C receptor influences innate immune response in ovarian cancer by decreasing the population of natural killer and TH-17 helper cells[J].Int J Oncol, 2013, 43 (4) :1011-1018.

[17]DU WJ, ZHEN JH, ZENG ZQ, et al.Expression of interleukin-17 associatedwith disease progression and liver fibrosis with hepatitis B virus infection:IL-17 in HBV infection[J].Diagn Pathol, 2013, 8:40.

[18]REDA R, ABBAS AA, MOHAMMED M, et al.The interplay between Zinc, Vitamin D and IL-17 in patients with chronic hepatitis C liver disease[J].J Immunol Res, 2015, 2015:846348.

[19]LLOSA NJ, GEIS AL, THIELE ORBERG E, et al.Interleukin-17 and type 17 helper T cells in cancer management and research[J].Immunotargets Ther, 2014, 3:39-54.

Relative Articles

[1]	Ting MAO, Mingyi XU, Jiayi WANG. Characteristics of T cells in the liver tissues of mice with nonalcoholic steatohepatitis[J]. Journal of Clinical Hepatology, 2025, 41(3): 461-468. doi: 10.12449/JCH250311
[2]	Shuang LI, Zherui LIU, Qi ZHAO, Yinying LU. Clinical research advances in chimeric antigen receptor T-cell therapy for primary liver cancer[J]. Journal of Clinical Hepatology, 2023, 39(5): 1019-1029. doi: 10.3969/j.issn.1001-5256.2023.05.004
[3]	Xue WEN, Yujing HE, Qianqian YUAN, Chuyi LI, Lixia LU, Xiaohui YU, Jiucong ZHANG. Expression of Sema4D in peripheral blood T cells and serum of patients with hepatitis B cirrhosis and its clinical significance[J]. Journal of Clinical Hepatology, 2023, 39(4): 810-817. doi: 10.3969/j.issn.1001-5256.2023.04.011
[4]	Ziyi LI, Wanjie ZHANG, Fuchun WANG, Xiaorong MAO, Junfeng LI. Role of T lymphocytes in primary sclerosing cholangitis[J]. Journal of Clinical Hepatology, 2023, 39(12): 2926-2931. doi: 10.3969/j.issn.1001-5256.2023.12.026
[5]	Huijuan FAN, Chun SONG. Expression of peripheral CD100 and its regulation to T lymphocytes function in patients with hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2023, 39(1): 128-136. doi: 10.3969/j.issn.1001-5256.2023.01.019
[6]	Mengkui HAN, Jin LI, Xiaohua YANG. Function and regulatory mechanism of T lymphocytes in tumor immune microenvironment of hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2022, 38(11): 2621-2626. doi: 10.3969/j.issn.1001-5256.2022.11.037
[7]	Xiaofei YANG, Linxu WANG, Changxing HUANG, Jie DONG, Haifeng HU, Zhanhu BI, Jianqi LIAN, Ye ZHANG. Mechanism of gamma-chain cytokines in regulating the expression of T-cell immunoglobulin and mucin domain-containing molecule 3 in CD8⁺ T cells of chronic hepatitis B patients[J]. Journal of Clinical Hepatology, 2021, 37(5): 1059-1064. doi: 10.3969/j.issn.1001-5256.2021.05.017
[8]	Wang HaoLiang, Deng GuoHong. Functional status of hepatitis B virus-specific T cells in patients with chronic hepatitis B virus infection:Exhausted or silenced?[J]. Journal of Clinical Hepatology, 2020, 36(5): 980-982. doi: 10.3969/j.issn.1001-5256.2020.05.005
[9]	Gao MengDan, Tan Ling, Sun JianPing, Li Kang, Li Ang, Lou JinLi, Zhang YongHong, Zhao Yan. Expression and significance of T-cell immunoglobulin and mucin domain-containing molecule 3 in peripheral blood CD3+CD56+ natural killer T cells in patients with hepatitis B virus-related acute-on-chronic liver failure[J]. Journal of Clinical Hepatology, 2019, 35(9): 2006-2010. doi: 10.3969/j.issn.1001-5256.2019.09.024
[10]	Gao Yi, Liang ZhiJun, Fu Jian. Influence of interleukin-35 on peripheral CD8+ T cell function in patients with acute-on-chronic liver failure[J]. Journal of Clinical Hepatology, 2019, 35(9): 2011-2016. doi: 10.3969/j.issn.1001-5256.2019.09.025
[11]	Ge KuanXue, Gao WeiHua, Xiang XiaoXing. Association of regulatory T cells, T helper 17 cells, and change in their balance with autoimmune hepatitis[J]. Journal of Clinical Hepatology, 2018, 34(7): 1573-1576. doi: 10.3969/j.issn.1001-5256.2018.07.045
[12]	Xiong KeGong, Ke KunYu, Kong JinFeng, Liu LiJuan, Chen LiFang, Lin XiaoQin. Expression of programmed death-ligand 1 on peripheral blood T cells and its correlation with liver inflammation grade in patients with type 1 autoimmune hepatitis[J]. Journal of Clinical Hepatology, 2018, 34(6): 1248-1252. doi: 10.3969/j.issn.1001-5256.2018.06.023
[13]	Zhang Ke, Yang Fan, Sun YanLing, Liu ZhenWen, Wang FuSheng, Shi Ming. Characteristics and clinical significance of peripheral follicular cytotoxic T cells in patients experiencing acute rejection after liver transplantation[J]. Journal of Clinical Hepatology, 2017, 33(7): 1336-1339. doi: 10.3969/j.issn.1001-5256.2017.07.027
[14]	Yin SiHan, Liu Peng, Zhang Tao, Sun KeWei. Analysis of TCM deficiency and excess attributes in patients with HBV- related acute- on- chronic liver failure based on phenotype of dendritic cells and function of T lymphocytes[J]. Journal of Clinical Hepatology, 2016, 32(4): 663-668. doi: 10.3969/j.issn.1001-5256.2016.04.010
[15]	Hou YuLi, Zhang YongHong, Zhao Yan. Immunological characteristics of tumor antigen specific T cells and their possible mechanisms in hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2016, 32(6): 1220-1224. doi: 10.3969/j.issn.1001-5256.2016.06.048
[16]	Cao Hui, Zhang Yang, Tan ShanZhong, Zhao Lei, Shen JianJun, Xiao Qian, Liang ZhongFeng, Jiang ShuLian. Relationship between percentages of T lymphocytes in peripheral blood and deficiency of vital qi in patients with HBV- ACLF[J]. Journal of Clinical Hepatology, 2014, 30(4): 320-323. doi: 10.3969/j.issn.1001-5256.2014.04.009
[17]	Zhao DanTong, Yan HuiPing, Liao HuiYu, Liu YanMin, Feng Xia, Zhao Yan, Liu XiuHong, Kong XiangSha. Expression of Toll like receptors on peripheral blood mononuclear cells and their influence on CD4+CD25+T regula- tory cells in patients with primary biliary cirrhosis[J]. Journal of Clinical Hepatology, 2012, 28(1): 58-62.
[18]	Lu XiaoJu, Chen YongPing, Yang Tao, Cheng Yuan, Jin XiaoZhi, Shen ChunYan, Liu Jun, Wang ChunYing, Wang XiaoDong, Lin Zhuo. The influence of regulatory T cells in hepatic stellate cell proliferation and HA secretion[J]. Journal of Clinical Hepatology, 2012, 28(1): 39-43.
[19]	Li Li, Chen Ming, Pan XiuCheng, Wang LiPing, Fu JuanJuan, Feng Xia. Correlation between the recent thymic output function and the frequency of nave T cell in CHB patients[J]. Journal of Clinical Hepatology, 2011, 27(2): 157-160.

Supplements(0)

Cited By

Cited by

Periodical cited type(2)

1.	张雄乐，陈芬兰，林文. 甲泼尼龙联合抗病毒药物治疗对乙型肝炎早期肝衰竭患者肝功能及炎性因子的影响. 中国医药指南. 2023(34): 98-101 .
2.	吴刚，叶晓玲，张宇，石磬. 单免疫球蛋白-白介素1受体蛋白在慢性乙肝患者中的表达水平变化及临床意义研究. 罕少疾病杂志. 2023(12): 72-74 .

Other cited types(3)

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (434) PDF downloads(71)

Association of serum interleukin-17 level with early recurrence and prognosis after radical surgery in hepatocellular carcinoma patients with different levels of alpha-fetoprotein

DOI: 10.3969/j.issn.1001-5256.2018.02.016

Abstract

References

Relative Articles

Cited by

Periodical cited type(2)

Other cited types(3)

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Association of serum interleukin-17 level with early recurrence and prognosis after radical surgery in hepatocellular carcinoma patients with different levels of alpha-fetoprotein

DOI: 10.3969/j.issn.1001-5256.2018.02.016

Abstract

References

Relative Articles

Cited by

Periodical cited type(2)

Other cited types(3)

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content